103,974 Shares in Surrozen, Inc. $SRZN Purchased by Empery Asset Management LP

Posted by Brian Himes on Jun 11th, 2026

Empery Asset Management LP acquired a new position in shares of Surrozen, Inc. (NASDAQ:SRZN – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 103,974 shares of the company’s stock, valued at approximately $2,350,000. Surrozen accounts for 2.1% of Empery Asset Management LP’s investment portfolio, making the stock its 10th biggest holding.

Other institutional investors and hedge funds have also bought and sold shares of the company. China Universal Asset Management Co. Ltd. lifted its position in Surrozen by 50.0% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 1,500 shares of the company’s stock worth $34,000 after purchasing an additional 500 shares during the period. Citadel Advisors LLC lifted its holdings in shares of Surrozen by 32.8% in the third quarter. Citadel Advisors LLC now owns 13,875 shares of the company’s stock worth $179,000 after acquiring an additional 3,424 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Surrozen by 22.6% in the second quarter. Geode Capital Management LLC now owns 30,963 shares of the company’s stock worth $277,000 after acquiring an additional 5,702 shares during the last quarter. Armistice Capital LLC bought a new position in shares of Surrozen in the second quarter worth about $536,000. Finally, Goldman Sachs Group Inc. bought a new position in shares of Surrozen in the fourth quarter worth about $584,000. Institutional investors own 66.57% of the company’s stock.

Wall Street Analysts Forecast Growth

SRZN has been the subject of a number of research reports. TD Cowen initiated coverage on shares of Surrozen in a report on Tuesday, April 21st. They issued a “buy” rating for the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $40.00 target price on shares of Surrozen in a report on Tuesday, March 24th. HC Wainwright reissued a “buy” rating and issued a $44.00 target price (up from $36.00) on shares of Surrozen in a report on Thursday, May 7th. Wall Street Zen raised shares of Surrozen from a “sell” rating to a “hold” rating in a report on Saturday, March 28th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Surrozen in a report on Tuesday, April 21st. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $42.00.

Get Our Latest Analysis on Surrozen

Surrozen Price Performance

Shares of NASDAQ SRZN opened at $21.77 on Thursday. The company has a 50 day simple moving average of $28.13 and a 200 day simple moving average of $24.56. The firm has a market cap of $252.75 million, a PE ratio of -0.58 and a beta of 0.51. Surrozen, Inc. has a 1 year low of $8.00 and a 1 year high of $35.00.

Surrozen (NASDAQ:SRZN – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported ($11.65) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.09) by ($10.56). The firm had revenue of $5.00 million for the quarter, compared to analyst estimates of $4.00 million. Surrozen had a negative net margin of 4,810.50% and a negative return on equity of 4,055.04%. As a group, research analysts anticipate that Surrozen, Inc. will post -7.2 earnings per share for the current fiscal year.

Insider Activity

In other news, major shareholder Tcg Crossover Gp Ii, Llc bought 106,658 shares of the firm’s stock in a transaction on Tuesday, March 24th. The stock was acquired at an average price of $24.69 per share, with a total value of $2,633,386.02. Following the transaction, the insider owned 736,554 shares of the company’s stock, valued at $18,185,518.26. This trade represents a 16.93% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Yang Li sold 1,584 shares of the stock in a transaction that occurred on Monday, May 4th. The shares were sold at an average price of $33.33, for a total transaction of $52,794.72. Following the sale, the vice president directly owned 17,216 shares of the company’s stock, valued at $573,809.28. This represents a 8.43% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders acquired 158,504 shares of company stock worth $3,923,750 and sold 8,144 shares worth $271,440. 31.74% of the stock is currently owned by company insiders.

About Surrozen

(Free Report)

Surrozen, Inc is a clinical-stage biopharmaceutical company focused on developing novel therapeutic antibodies that target the Wnt signaling pathway for applications in tissue repair, regeneration and oncology. Founded in 2012 and headquartered in South San Francisco, California, the company leverages its proprietary SurroBody platform to design bispecific antibody molecules capable of modulating Wnt receptor activity with enhanced tissue specificity.

The SurroBody platform enables the generation of high-affinity, dual-binding antibodies engineered to either activate or inhibit Wnt signaling, a pathway critical to cell proliferation, differentiation and homeostasis.